Topical Amlexanox data

CHMX (Fort Lee, N.J.) announced that Phase III trials showed statistically significant results in treating the ulcers, which will support filing of an NDA in August.

Two Phase III trials at 23 dental schools in the U.S. and one in Canada enrolled 952 patients. The company reported accelerated healing and complete resolution of pain, with few local adverse reactions, but declined to give further details. ...